Client 1st Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$281K Sell
2,189
-407
-16% -$47.6K 0.07% 117
2026
Q1
$312K Sell
2,596
-250
-9% -$28.9K 0.09% 99
2025
Q4
$300K Buy
+2,846
New +$267K 0.09% 109

Other funds holding MRK

Client 1st Advisory Group's MRK Position: Q2 2026 in Review

Client 1st Advisory Group reduced its Merck (MRK) stake by 16% in Q2 2026, selling an estimated $47.6K and leaving 2,189 shares worth $281K. The position accounts for 0.07% of the portfolio, ranked #117.

Client 1st Advisory Group first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $312K in Q1 2026. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Client 1st Advisory Group held 2,189 shares of Merck worth $281K as of Q2 2026.
  • Client 1st Advisory Group sold 407 Merck shares in Q2 2026, an estimated $47.6K.
  • Merck made up 0.07% of Client 1st Advisory Group's portfolio in Q2 2026, its #117 holding.
  • Client 1st Advisory Group first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Client 1st Advisory Group's Merck position peaked at $312K in Q1 2026.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Client 1st Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.